Stay updated with breaking news from Lead Optimisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
University of Cambridge spin-out DeepMirror, software developers for the discovery of novel therapeutic drugs, has launched an Early Access Programme after a successful closed beta programme during which chemists were invited to test the software over several months. Click to read more...
DeepMirror, a University of Cambridge spin-out, introduces its Early Access Programme for intuitive design software dedicated to discovering innovative therapeutic drugs. Click to read more...
Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery.
C4X Discovery Holdings PLC Announces Half Year Results
EQS-News: Proteros biostructures GmbH / Key word(s): Financing Proteros receives minority investment from private equity firm Inflexion 09.01.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Proteros receives minority investment from private equity fir...